The estimated Net Worth of Moshe Citronowicz is at least $1.3 Milion dollars as of 11 July 2022. Mr. Citronowicz owns over 30,000 units of Apyx Medical stock worth over $575,195 and over the last 9 years he sold APYX stock worth over $0. In addition, he makes $721,355 as Senior Vice President at Apyx Medical.
Moshe has made over 2 trades of the Apyx Medical stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 30,000 units of APYX stock worth $76,200 on 11 July 2022.
The largest trade he's ever made was exercising 30,000 units of Apyx Medical stock on 11 July 2022 worth over $76,200. On average, Moshe trades about 5,556 units every 266 days since 2015. As of 11 July 2022 he still owns at least 456,504 units of Apyx Medical stock.
You can see the complete history of Mr. Citronowicz stock trades at the bottom of the page.
Moshe Citronowicz is the Senior Vice President of the Company. He is came to the United States in 1978 and has worked in a variety of manufacturing and high technology industries. In October 1993, Mr. Citronowicz joined the Company as Vice President of Operations and served as our Chief Operating Officer until November 2011. Currently, he is serving as the Senior Vice President. Mr. Citronowicz’s employment contract extends to December 31, 2020.
As the Senior Vice President of Apyx Medical, the total compensation of Moshe Citronowicz at Apyx Medical is $721,355. There are 2 executives at Apyx Medical getting paid more, with Charles Goodwin having the highest compensation of $1,945,260.
Moshe Citronowicz is 67, he's been the Senior Vice President of Apyx Medical since 2011. There are 5 older and 7 younger executives at Apyx Medical. The oldest executive at Apyx Medical Corporation is Andrew Makrides, 78, who is the Independent Chairman of the Board.
Moshe's mailing address filed with the SEC is C/O APYX MEDICAL CORPORATION, 5115 ULMERTON ROAD, CLEARWATER, FL, 33760.
Over the last 6 years, insiders at Apyx Medical have traded over $0 worth of Apyx Medical stock and bought 97,836 units worth $253,260 . The most active insiders traders include Stavros G. Vizirgianakis, Charles D. Ii Goodwin oraz Moshe Citronowicz. On average, Apyx Medical executives and independent directors trade stock every 86 days with the average trade being worth of $18,719. The most recent stock trade was executed by Matthew C Hill on 13 August 2024, trading 5,336 units of APYX stock currently worth $6,030.
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and OEM. It offers electrosurgical generators based on its Helium Plasma Technology for cutting, coagulation, and ablation of soft tissue. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market that allows surgeons to operate with precision and eliminate unintended tissue trauma. It also develops, manufactures, and sells energy generators, disposable hand piece subassemblies, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Apyx Medical executives and other stock owners filed with the SEC include: